Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer

NCT02960061 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

640

Enrollment

OTHER

Sponsor class

Conditions

Survival

Interventions

DRUG: Neoadjuvant chemotherapy
PROCEDURE: D2 radical resection
DRUG: Hyperthermic intraperitoneal perfusion chemotherapy
DRUG: Adjuvant chemotherapy

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University